These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 21424692)

  • 1. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
    Gauthier J; Siddiqui TJ; Huashan P; Yokomaku D; Hamdan FF; Champagne N; Lapointe M; Spiegelman D; Noreau A; Lafrenière RG; Fathalli F; Joober R; Krebs MO; DeLisi LE; Mottron L; Fombonne E; Michaud JL; Drapeau P; Carbonetto S; Craig AM; Rouleau GA
    Hum Genet; 2011 Oct; 130(4):563-73. PubMed ID: 21424692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
    Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL
    PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures.
    Lionel AC; Vaags AK; Sato D; Gazzellone MJ; Mitchell EB; Chen HY; Costain G; Walker S; Egger G; Thiruvahindrapuram B; Merico D; Prasad A; Anagnostou E; Fombonne E; Zwaigenbaum L; Roberts W; Szatmari P; Fernandez BA; Georgieva L; Brzustowicz LM; Roetzer K; Kaschnitz W; Vincent JB; Windpassinger C; Marshall CR; Trifiletti RR; Kirmani S; Kirov G; Petek E; Hodge JC; Bassett AS; Scherer SW
    Hum Mol Genet; 2013 May; 22(10):2055-66. PubMed ID: 23393157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare deletions at the neurexin 3 locus in autism spectrum disorder.
    Vaags AK; Lionel AC; Sato D; Goodenberger M; Stein QP; Curran S; Ogilvie C; Ahn JW; Drmic I; Senman L; Chrysler C; Thompson A; Russell C; Prasad A; Walker S; Pinto D; Marshall CR; Stavropoulos DJ; Zwaigenbaum L; Fernandez BA; Fombonne E; Bolton PF; Collier DA; Hodge JC; Roberts W; Szatmari P; Scherer SW
    Am J Hum Genet; 2012 Jan; 90(1):133-41. PubMed ID: 22209245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the neurexin 1 gene is associated with schizophrenia.
    Rujescu D; Ingason A; Cichon S; Pietiläinen OP; Barnes MR; Toulopoulou T; Picchioni M; Vassos E; Ettinger U; Bramon E; Murray R; Ruggeri M; Tosato S; Bonetto C; Steinberg S; Sigurdsson E; Sigmundsson T; Petursson H; Gylfason A; Olason PI; Hardarsson G; Jonsdottir GA; Gustafsson O; Fossdal R; Giegling I; Möller HJ; Hartmann AM; Hoffmann P; Crombie C; Fraser G; Walker N; Lonnqvist J; Suvisaari J; Tuulio-Henriksson A; Djurovic S; Melle I; Andreassen OA; Hansen T; Werge T; Kiemeney LA; Franke B; Veltman J; Buizer-Voskamp JE; ; Sabatti C; Ophoff RA; Rietschel M; Nöthen MM; Stefansson K; Peltonen L; St Clair D; Stefansson H; Collier DA
    Hum Mol Genet; 2009 Mar; 18(5):988-96. PubMed ID: 18945720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation screening of the neurexin 1 gene in thai patients with intellectual disability and autism spectrum disorder.
    Yangngam S; Plong-On O; Sripo T; Roongpraiwan R; Hansakunachai T; Wirojanan J; Sombuntham T; Ruangdaraganon N; Limprasert P
    Genet Test Mol Biomarkers; 2014 Jul; 18(7):510-5. PubMed ID: 24832020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.
    Gregor A; Albrecht B; Bader I; Bijlsma EK; Ekici AB; Engels H; Hackmann K; Horn D; Hoyer J; Klapecki J; Kohlhase J; Maystadt I; Nagl S; Prott E; Tinschert S; Ullmann R; Wohlleber E; Woods G; Reis A; Rauch A; Zweier C
    BMC Med Genet; 2011 Aug; 12():106. PubMed ID: 21827697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.
    Tarabeux J; Kebir O; Gauthier J; Hamdan FF; Xiong L; Piton A; Spiegelman D; Henrion É; Millet B; ; Fathalli F; Joober R; Rapoport JL; DeLisi LE; Fombonne É; Mottron L; Forget-Dubois N; Boivin M; Michaud JL; Drapeau P; Lafrenière RG; Rouleau GA; Krebs MO
    Transl Psychiatry; 2011 Nov; 1(11):e55. PubMed ID: 22833210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders.
    Duong L; Klitten LL; Møller RS; Ingason A; Jakobsen KD; Skjødt C; Didriksen M; Hjalgrim H; Werge T; Tommerup N
    Am J Med Genet B Neuropsychiatr Genet; 2012 Apr; 159B(3):354-8. PubMed ID: 22337556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila.
    Zweier C; de Jong EK; Zweier M; Orrico A; Ousager LB; Collins AL; Bijlsma EK; Oortveld MA; Ekici AB; Reis A; Schenck A; Rauch A
    Am J Hum Genet; 2009 Nov; 85(5):655-66. PubMed ID: 19896112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intragenic rearrangements in NRXN1 in three families with autism spectrum disorder, developmental delay, and speech delay.
    Wiśniowiecka-Kowalnik B; Nesteruk M; Peters SU; Xia Z; Cooper ML; Savage S; Amato RS; Bader P; Browning MF; Haun CL; Duda AW; Cheung SW; Stankiewicz P
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jul; 153B(5):983-93. PubMed ID: 20162629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare heterozygous genetic variants of NRXN and NLGN gene families involved in synaptic function and their association with neurodevelopmental disorders.
    Gerik-Celebi HB; Bolat H; Unsel-Bolat G
    Dev Neurobiol; 2024 Jul; 84(3):158-168. PubMed ID: 38739110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare exonic NRXN3 deletion segregating with neurodevelopmental and neuropsychiatric conditions in a three-generation Chinese family.
    Yuan H; Wang Q; Liu Y; Yang W; He Y; Gusella JF; Song J; Shen Y
    Am J Med Genet B Neuropsychiatr Genet; 2018 Sep; 177(6):589-595. PubMed ID: 30076746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurexin gene family variants as risk factors for autism spectrum disorder.
    Wang J; Gong J; Li L; Chen Y; Liu L; Gu H; Luo X; Hou F; Zhang J; Song R
    Autism Res; 2018 Jan; 11(1):37-43. PubMed ID: 29045040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous exonic and intragenic NRXN1 deletion presenting as either West syndrome or autism spectrum disorder in two siblings.
    Aksu Uzunhan T; Ayaz A
    Clin Neurol Neurosurg; 2022 Mar; 214():107141. PubMed ID: 35101781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.
    Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ
    Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia.
    Ishizuka K; Yoshida T; Kawabata T; Imai A; Mori H; Kimura H; Inada T; Okahisa Y; Egawa J; Usami M; Kushima I; Morikawa M; Okada T; Ikeda M; Branko A; Mori D; Someya T; Iwata N; Ozaki N
    J Neurodev Disord; 2020 Sep; 12(1):25. PubMed ID: 32942984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia.
    Piton A; Gauthier J; Hamdan FF; Lafrenière RG; Yang Y; Henrion E; Laurent S; Noreau A; Thibodeau P; Karemera L; Spiegelman D; Kuku F; Duguay J; Destroismaisons L; Jolivet P; Côté M; Lachapelle K; Diallo O; Raymond A; Marineau C; Champagne N; Xiong L; Gaspar C; Rivière JB; Tarabeux J; Cossette P; Krebs MO; Rapoport JL; Addington A; Delisi LE; Mottron L; Joober R; Fombonne E; Drapeau P; Rouleau GA
    Mol Psychiatry; 2011 Aug; 16(8):867-80. PubMed ID: 20479760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1.
    Pak C; Danko T; Zhang Y; Aoto J; Anderson G; Maxeiner S; Yi F; Wernig M; Südhof TC
    Cell Stem Cell; 2015 Sep; 17(3):316-28. PubMed ID: 26279266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic regulation of Nrxn1 [corrected] expression: an integrative cross-species analysis of schizophrenia candidate genes.
    Mozhui K; Wang X; Chen J; Mulligan MK; Li Z; Ingles J; Chen X; Lu L; Williams RW
    Transl Psychiatry; 2011 Jul; 1(7):e25. PubMed ID: 22832527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.